6PB-24974-71436
1 vaccination
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 601 / IL
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Registered in v-safe
-
2021-03-04
Survey response — day 7, dose 1MedDRA: Fatigue, Headache, Injection site mass, Pain — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: On 2/19, approximately 5 hrs after receiving the vaccine, I did start to experience a severe headache & body aches. I was very tired & fatigued. Around 8 hrs after receiving the vaccine my temp was 99.9 degrees Fahrenheit & I remained with all those symptoms for approximately 18hrs afyer vaccine administration. Additionally, I had a painful lump approximately 2cm in diameter at the injection site that remained for approximately 72-96 hrs after vaccine administration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech |
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): On 2/19, approximately 5 hrs after receiving the vaccine, I did start to experience a severe headache & body aches. I was very tired & fatigued. Around 8 hrs after receiving the vaccine my temp was 99.9 degrees Fahrenheit & I remained with all those symptoms for approximately 18hrs afyer vaccine administration. Additionally, I had a painful lump approximately 2cm in diameter at the injection site that remained for approximately 72-96 hrs after vaccine administration.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release